pharmaphorum

NOVEMBER 23, 2022

Dengue is a mosquito-borne virus endemic in more than 125 countries, including the US territories of Puerto Rico, the US Virgin Islands, and American Samoa, and is a leading cause of fever among travellers to Latin America, the Caribbean, and Southeast Asia.

FDA 122

FDA Marketing Leads Safety 122

pharmaphorum

OCTOBER 31, 2022

The small-molecule PIKfyve inhibitor – called VRG50635 – has been administered to the first subject in the phase 1 trial involving healthy volunteers, according to the San Francisco-based biotech, which was founded in 2015 by Alice Zhang and Jason Chen. Alice Zhang.

Pharma 136

Pharma Leads Medicine Marketing 136

pharmaphorum

NOVEMBER 11, 2022

According to court documents, Cohen reached out in 2015 to Moshe Alafi, former general partner at Alafi Capital who he had known for decades – and his son Christopher Alafi, who is the firm’s capital director – to seek investment in Nuredis. ” pharmaphorum has contacted Dr Cohen for comment on the case.

Leads 113

Leads FDA Marketing 113

Pharma Pathway

JANUARY 6, 2023

is a Private incorporated on 24 July 2015. We are leading API Bulk Drug Manufacturing Company approved by USFDA located near Choutuppal. -Walk-Ins for Quality Control/ Production/ Production Documentation/ EHS On 7th Jan’ 2023. Job Description. Dasami Lab Pvt. It is classified as Non-govt. Dasami Lab Pvt.

Manufacturing 83

Manufacturing Leads Pharma 83

World of DTC Marketing

MARCH 19, 2021

In actual numbers, in 2015, poor diet was associated with over 52,200 colorectal cancer cases; over 14,400 mouth, pharynx and larynx cancers ; nearly 3,200 uterine cancers ; just over 3,000 cases of breast cancer in postmenopausal women; 2,000 kidney cancers ; nearly 1,600 stomach cancers ; and 1,000 liver cancers.

Healthcare 143

Healthcare Healthcare Side effects Medical 143

European Pharmaceutical Review

JULY 7, 2022

He then had a one-year stint at Merck Research Laboratories as Director of Clinical Research for Clinical Hepatology before returning to Bristol Myers-Squibb from 2010-2015. ” Since September 2021, Dr Hughes has been Senior Vice President of Clinical Development and Translational Medicine at Vertex Pharmaceuticals, based in Boston.

Medical 98

Medical Medicine Pharmaceutical Leads 98

European Pharmaceutical Review

JANUARY 9, 2024

The development of AI in and its application to the production process are all going to lead us into a new era where drugs are safer, more effective, and focused on treating patients. 2015; 13:8-17. 2015; 12(10):931-934. One of its most useful aspects is that answers to many questions come readily from data analysis.

Pharmaceutical manufacturing 122

Pharmaceutical manufacturing Manufacturing Pharmaceutical Food and Drug Administration 122

World of DTC Marketing

JUNE 4, 2021

Mike always battled weight issues, but since he went out on disability, he had gained more weight, leading to diabetes. An unhealthy diet is one of the leading risk factors for poor health and accounts for up to 45% of all deaths from these cardiometabolic diseases, the researchers noted. 1ne: We eat out — a lot.

Food 207

Food Insurance Leads Medical 207

pharmaphorum

OCTOBER 28, 2022

Nina Pinwill leads the commercial operations function within the Commercial Medicines Directorate at NHS England. Alongside his work as a recognised author, speaker, moderator and industry advisor, he founded the industry-leading publication pharmaphorum in 2009. She is an SME in market access, rare disease and biosimilars.

Medicine 122

Medicine Management Marketing Leads 122

European Pharmaceutical Review

AUGUST 8, 2022

Dan Miller of Walden Macht & Haran, lead counsel to Streck, commented on the decision: “The jury has spoken. million) in 2015 , also for knowingly underpaying Medicaid rebates. Eli Lilly knowingly violated the False Claims Act and defrauded the Medicaid Program of $61 million in taxpayer money. . million) and Cephalon ($7.5

Manufacturing 98

Manufacturing Pharmaceutical Pharma Leads 98

European Pharmaceutical Review

JANUARY 25, 2023

Collaboration between Vertex and CRISPR Therapeutics Vertex and CRISPR Therapeutics entered into a strategic research collaboration in 2015 focused on the use of CRISPR/Cas9 to discover and develop potential new treatments aimed at the underlying genetic causes of human disease. Costs and profits worldwide are shared with CRISPR Therapeutics.

Medicine 111

Medicine Food and Drug Administration FDA Pharmaceutical 111

pharmaphorum

AUGUST 23, 2022

It isn’t the first dengue vaccine to reach the market, but is free of the severe restrictions that have held back its only predecessor, Sanofi’s Dengvaxia , which was cleared for marketing in 2015. Dengue fever is unusual in that a first infection is rarely serious, but a second can lead to much more serious disease.

Marketing 111

Marketing Food FDA Leads 111

European Pharmaceutical Review

APRIL 29, 2024

This means that patients with the rare genetic bleeding disorder can produce FIX themselves instead of relying on regular intravenous infusions of FIX, which is the current standard of care, according to 2015 research highlighted by Pfizer.

Food and Drug Administration 96

Food and Drug Administration Medicine FDA Food 96

European Pharmaceutical Review

JANUARY 18, 2024

GlobalData’s Analyst covering Neurology and Ophthalmology, Thomas Parker, MPharmacol, predicted that Belsomra would lead the market by 2023. Comparatively, in 2015, GlobalData’s research expected that sales of therapies for Gaucher disease will reach $1.16 million in sales by 2032. billion by 2024.

Marketing 98

Marketing Sales Pharmacology Pharma 98

pharmaphorum

OCTOBER 29, 2015

Findings from the Veeva 2015 European Life Sciences Survey Is the industry getting what it needs? Customer data challenges are among the most vexing and pervasive that life sciences companies currently experience, especially with the increasing regulatory pressure and the transition to new business models they face.

Leads 52

Leads Marketing Pharma 52

pharmaphorum

JANUARY 9, 2023

is to acquire the 2015-established Amryt Pharma Plc. Supported by voting agreements from leading Amryt shareholders and directors, and unanimously approved and recommended by the boards of both companies, the total transaction is worth up to $1.48 Biopharma and healthcare group Chiesi Farmaceutici S.p.A. on 6 th January.

Pharma 98

Pharma Biopharma Management Medicine 98

European Pharmaceutical Review

APRIL 27, 2023

His contributions “have been integral in the evolution of our portfolio over the past several years, notably building our leading presence in immuno-oncology, growing our CV business and launching multiple new medicines,” Samuels added. Theodore R Samuels will continue to serve as Lead Independent Director.

Medicine 94

Medicine Marketing Government Leads 94

European Pharmaceutical Review

AUGUST 26, 2022

Moderna claims that, when COVID-19 emerged, neither company had the same level of experience with “developing mRNA vaccines for infectious diseases” as Moderna, adding: “they knowingly followed Moderna’s lead in developing their own vaccine.”. ” But why sue now?

Sales 98

Sales Medicine Marketing Government 98

pharmaphorum

OCTOBER 7, 2022

BenevolentAI is a leading clinical-stage AI drug discovery company. The number of AI-based drug discovery strategic alliances has increased significantly in recent years: There were just 10 in 2015; in 2021, there were 105. By combining the power of AI with human expertise we are bringing new drug targets into our portfolio.”.

Sales 104

Sales Leads 104

pharmaphorum

SEPTEMBER 16, 2022

The companies hope that in the year to come those data targets will be entered for validation, hit generation, and lead selection. Next, they need experiential evidence that will support progressing these revealed prioritised targets into the discovery of lead molecules. Technological breakthroughs in molecular biology.

Leads 135

Leads Patients Medicine FDA 135

European Pharmaceutical Review

JUNE 30, 2023

Since the 1990s, the annual harvest of Chinese horseshoe crab ( Tachypleus tridentatus ) for biomedical purposes has dropped from 600,000 to 100,000 in 2015, the paper noted. This conservation leads to a greater usage efficiency of the volume of reagent.

Manufacturing 98

Manufacturing Pharmaceutical Prospecting Leads 98

European Pharmaceutical Review

JANUARY 24, 2023

She was medical lead at SIBAmed GmbH for four years. At Parexel, Sandra held roles in Phase I project management and business development, before being promoted to a senior portfolio director in 2015. There, she oversaw clinical trials, including coordination, execution and regulatory processes.

Key account management 98

Key account management Physicians Networking Management 98

European Pharmaceutical Review

OCTOBER 7, 2022

In the years 2015 and 2020, clinical-stage cancer programmes increased by a considerable 77 percent (1,642 to 2,911), resulting in a quarter of drugs currently in development worldwide being highly potent. Leading companies in the oral solid dosage market are Catalent, Inc.,

Manufacturing 98

Manufacturing Marketing Side effects Transportation 98

pharmaphorum

AUGUST 17, 2022

The deal will see Atomwise identify, synthesize, and advance lead compounds for up to five drug targets that will then be exclusively Sanofi’s to develop. That same report noted that the number of companies in the AI drug discovery space increased tenfold between 2015 and 2021.

Medicine 97

Medicine Pharma Engineering Sales 97

pharmaphorum

OCTOBER 7, 2022

IQVIA has the long term market data, from World Reviews back to 1978, to investigate, and analysed nearly 30 years of launches into leading therapy classes, from multiple eras in the development of the pharmaceutical industry. Is this true?

Competition 95

Competition Marketing Medicine Pharmaceutical 95

Legacy MEDSearch

AUGUST 8, 2022

was established in China in 2015 and is a subsidiary of MicroPort Scientific Corporation. About MicroPort NaviBot MicroPort NaviBot International LLC was incorporated in 2020 and is headquartered in Foxborough, MA. NaviBot is subsidiary of MicroPort MedBot. About MicroPort MedBot Shanghai MicroPort MedBot (Group) Co.,

Food and Drug Administration 98

Food and Drug Administration Recruitment Medical Food 98

PM360

JULY 18, 2022

FINN Partners , an independent marketing and communications agency, is expanding its global footprint even further with the addition of SPAG , a leading, Asia-headquartered, health-sector communications and marketing firm with offices in Bangalore, Delhi, Indonesia, Malaysia, Mumbai, the Philippines, and Singapore.

Biopharma 96

Biopharma Management Marketing Leads 96

Spotio

MAY 10, 2023

Business-to-business (B2B) prospecting is the pillar of lead generation. According to Technology Advice , 70% of marketers at B2B companies reported that “improving lead quality” was the primary concern. Also, 54%said getting more leads was a top objective as well. Also, 54%said getting more leads was a top objective as well.

B2B Sales 98

B2B Sales Prospecting Sales CRM 98

Clarivate

DECEMBER 8, 2021

Starting with 12,147 Research Fronts, representing papers published and cited between 2015 and 2020, the next step was to select the fronts containing core literature that is both highly cited and recent – a measure of particularly active and fast-moving research.

Specialization 98

Specialization Leads Government Medical 98

European Pharmaceutical Review

MARCH 11, 2024

In fact, a study published in 2023 in The Lancet HIV revealed that women and men with HIV at age 40 had an average of 39 and 37 years of life left, respectively – only a few years less than that of the general population – if they started antiretroviral therapy (ART) after 2015. World Health Organization. The Global Health Observatory.

Medicine 98

Medicine Pharmacology Healthcare Healthcare 98

Eversana Intouch

OCTOBER 13, 2023

10 The more than 350 program initiatives address economic stability, education access/quality, health care access/quality, neighborhood/built environment and social/community context, 2 and focus on 23 high-priority leading health indicators (LHIs) that impact major causes of death and disease in the United States. August 2015.

Pharma 105

Pharma Education Government Pharmaceutical 105

Pharmaceutical Technology

DECEMBER 6, 2022

The three leading Alzheimer’s disease (AD) drugs currently in development are all monoclonal antibodies—donanemab by Eli Lilly , lecanemab by Eisai and Biogen , and gantenerumab by Roche. AD currently affects more than 55 million people worldwide. Monoclonal antibodies make up half of these, with an 11% share of all AD approvals.

Marketing 59

Marketing Leads Pharmaceutical FDA 59

European Pharmaceutical Review

JULY 25, 2022

According to the latest WHO estimates in 2015, this duped consumer base accounts for 50 percent of all online drug purchases. The growing complexity of supply chains – due to increased moving parts and geographies, faster lead times, limited visibility and greater product variability – creates havoc for anti-counterfeiting efforts.

Pharmaceutical 104

Pharmaceutical Medicine Pharmaceutical manufacturing Manufacturing 104

pharmaphorum

NOVEMBER 6, 2017

The Cancer Vanguard is a bold initiative setup to take leadership in the delivery of the National Cancer Strategy – Achieving World-Class Cancer Outcomes published in 2015 with a key aim of designing and implementing new and increasingly patient centric models of care in Cancer that can benefit and be adopted by the wider national cancer system.

Medicine 52

Medicine Pharma Patients Leads 52

Spotio

JULY 25, 2023

HubSpot – This all-in-one platform helps sales and marketing teams attract more site visitors, convert more leads, and close more sales. In 2015, an average of 5.4 Establish lead qualification criteria Almost 80% of leads never turn into sales. That means sales reps may waste time chasing leads that won’t convert.

B2B Sales 98

B2B Sales Sales Prospecting Sales process 98

European Pharmaceutical Review

MAY 11, 2023

In 2015, she joined Astellas Pharma, Northbrook, IL, and served as Global Lead for Immunology, CNS and Neuromuscular Indications and eventually as Global Medical Lead for the Muscle TA. She has led Clinical Development for Novartis Gene Therapies since 2020. Sitra joined Avexis in 2019 as Head of Clinical Development for SMA.

Food and Drug Administration 95

Food and Drug Administration Government Healthcare Healthcare 95

pharmaphorum

JANUARY 16, 2023

This is definitely not because all unmet need is addressed: the WHO reports that the three leading causes of death globally, and growing, are ischaemic heart disease, stroke, and chronic obstructive pulmonary disease. Alzheimer’s is currently the seventh-leading cause of death globally and growing fast.

FDA 98

FDA Healthcare Healthcare Medicine 98